Publications | PubMed=7037175 Reynolds C.P., Reynolds D.A., Frenkel E.P., Smith R.G. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant. Cancer Res. 42:1331-1336(1982) PubMed=3456456; DOI=10.1093/jnci/76.3.375 Reynolds C.P., Biedler J.L., Spengler B.A., Reynolds D.A., Ross R.A., Frenkel E.P., Smith R.G. Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst. 76:375-387(1986) PubMed=2535691 Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49:219-225(1989) PubMed=2019470; DOI=10.1002/ijc.2910480221 Sugimoto T., Ueyama H., Hosoi H., Inazawa J., Kato T., Kemshead J.T., Reynolds C.P., Gown A.M., Mine H., Sawada T. Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Int. J. Cancer 48:277-283(1991) DOI=10.1016/B978-0-12-333530-2.50006-X Israel M.A., Thiele C.J. Tumor cell lines of the peripheral nervous system. (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York (1994) DOI=10.1007/0-306-46872-7_2 Thiele C.J. Neuroblastoma. (In) Human cell culture. Vol. 1. Cancer Cell Lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York (1999) PubMed=12702577 Saito-Ohara F., Imoto I., Inoue J., Hosoi H., Nakagawara A., Sugimoto T., Inazawa J. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res. 63:1876-1883(2003) PubMed=15150091; DOI=10.1158/0008-5472.CAN-03-0809 Schaefer K.-L., Brachwitz K., Wai D.H., Braun Y., Diallo R., Korsching E., Eisenacher M., Voss R., van Valen F., Baer C., Selle B., Spahn L., Liao S.-K., Lee K.A.W., Hogendoorn P.C.W., Reifenberger G., Gabbert H.E., Poremba C. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Res. 64:3395-3405(2004) PubMed=15720811; DOI=10.1593/neo.04310 Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.-F., Biedler J.L., Cheung N.-K.V., Ross R.A. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 6:838-845(2004) PubMed=15892104; DOI=10.1002/gcc.20198 Mosse Y.P., Greshock J., Margolin A.A., Naylor T., Cole K., Khazi D., Hii G., Winter C., Shahzad S., Asziz M.U., Biegel J.A., Weber B.L., Maris J.M. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43:390-403(2005) PubMed=16822308; DOI=10.1186/1471-2407-6-177 Dam V., Morgan B.T., Mazanek P., Hogarty M.D. Mutations in PIK3CA are infrequent in neuroblastoma. BMC Cancer 6:177.1-177.10(2006) PubMed=18724359; DOI=10.1038/nature07261 Mosse Y.P., Laudenslager M., Longo L., Cole K.A., Wood A., Attiyeh E.F., Laquaglia M.J., Sennett R., Lynch J.E., Perri P., Laureys G., Speleman F., Kim C., Hou C.-P., Hakonarson H., Torkamani A., Schork N.J., Brodeur G.M., Tonini G.P., Rappaport E., Devoto M., Maris J.M. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930-935(2008) PubMed=23202128; DOI=10.1038/ng.2493 Sausen M., Leary R.J., Jones S., Wu J., Reynolds C.P., Liu X.-Y., Blackford A.L., Parmigiani G., Diaz L.A. Jr., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E., Hogarty M.D. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45:12-17(2013) PubMed=24792489; DOI=10.1007/s11060-014-1456-8 Farooqi A.S., Dagg R.A., Choi L.M.R., Shay J.W., Reynolds C.P., Lau L.M.S. Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations. J. Neurooncol. 119:17-26(2014) PubMed=25884760; DOI=10.1371/journal.pcbi.1004130 Palacios-Moreno J., Foltz L., Guo A.-L., Stokes M.P., Kuehn E.D., George L., Comb M.J., Grimes M.L. Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput. Biol. 11:e1004130.1-e1004130.33(2015) PubMed=26342562; DOI=10.1016/j.scr.2015.08.008 Ross R.A., Walton J.D., Han D., Guo H.-F., Cheung N.-K.V. A distinct gene expression signature characterizes human neuroblastoma cancer stem cells. Stem Cell Res. 15:419-426(2015) |